Gem Pharmaceuticals
Birmingham · Founded 2003
About Gem Pharmaceuticals
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.
Company Facts
- Founded: 2003
- Legal name: Gem Pharmaceuticals LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.5M
- Last round: Series Unknown (Mar 2014)
- Website: gempharmaceuticals.com
- Phone: +1 205-982-8383
Canonical: https://fsome.com/organization/gem-pharmaceuticals-8293052 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.